Cardiovascular
Credibility 86
Intensive blood-pressure control for the prevention of major cardiovascular events in patients with type 2 diabetes: Rationale, design and baseline characteristics of the OPTIMAL-DIABETES randomized trial.
December 24, 2026 · American heart journal
Key takeaway
This study is *still ongoing* and doesn't have results yet. It is designed to see if aiming for lower blood pressure (under 120) is better than a slightly higher goal (under 140) for Black adults and other diverse groups with type 2 diabetes, to prevent heart attacks and strokes. This matters because it will help us understand the best blood pressure targets for our community, who often face higher risks.
Why this matters for our communities
Research in cardiovascular helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.
More in Cardiovascular
December 31, 2026Social determinants of health associated with multiple myeloma incidence and survival among a low-income cohort in the Southeastern U.S.Read December 31, 2026Barriers and facilitators of cardiovascular disease prevention among people with HIV in the Southern United States: a photo-elicitation study.Read December 31, 2026Heart failure among people with HIV: prescription of guideline-directed medical therapy.Read